Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30 + Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program

Published 2016 View Full Article

Authors

Keywords

Journal

HAEMATOLOGICA

Volume 101, Issue 4, Pages 466-473

Publisher

Ferrata Storti Foundation (Haematologica)

Online

2016-01-15

DOI

10.3324/haematol.2015.134213

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

HAEMATOLOGICA

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Add your recorded webinar